Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
Frontiers in Oncology · 14.09.2023 · 13
DOI: 10.3389/fonc.2023.1208320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 14.09.2023. Verfasst von Eun-Gyeong Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Center.
Abstract (Originalsprache)
Background
Second primary cancer has become an important issue among cancer survivors. This study sought to determine the differences in clinicopathologic outcomes between second primary breast cancer (SPBC) after ovarian cancer and primary breast cancer (PBC) in the Republic of Korea. Methods and materials We searched the Korea Central Cancer Registry and identified 251,244 breast cancer cases that were diagnosed between 1999 and 2017. The incident rate and standardized incidence ratio (SIR) were calculated. Demographic and clinical characteristics and overall survival (OS) rates were estimated according to age, histological type, and cancer stage.
Results
Among the 228,329 patients included, 228,148 were patients with PBC, and 181 patients had SPBC diagnosed after ovarian cancer (OC). The mean ages at diagnosis were 56.09 ± 10.81 years for SPBC and 50.65 ± 11.40 years for PBC. Patients with SPBC were significantly less likely than patients with PBC to receive adjuvant radiotherapy (14.92% vs. 21.92%, p = 0.02) or adjuvant chemotherapy (44.75% vs. 55.69%, p < 0.01). Based on the age-standardized rate (ASR), the incidence of SPBC after OC was 293.58 per 100,000 ovarian cancer patients and the incidence of PBC was 39.13 per 100,000 women. The SIR for SPBC was 1.27 (1.09-1.46, 95% Confidence interval) in the patients overall. The 5-year OS rates were 72.88% and 89.37% for SPBC and PBC ( p < 0.01). The OS rate in SPBC decreased significantly with advanced stage and older age.
Conclusion
The incidence of breast cancer is about 1.27 times higher in ovarian cancer patients than in healthy people. The survival outcomes were worse for SPBC than for PBC and were related to older age and advanced stage. Active screening for breast cancer is necessary in ovarian cancer patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
- Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
- Department of Obstetrics and Gynecology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea.
- Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
- Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Republic of Korea.
- Division of Tumor Immunology, Research Institute, National Cancer Center, Goyang, Republic of Korea.
Förderung
- National Cancer Center
Zitieren
APA
Lee, E. G., Lim, J., Ha, H. I., Lim, M. C., Chang, Y. J., Won, Y. J., & Jung, S. Y. (2023). Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1208320
Vancouver
Lee EG, Lim J, Ha HI, Lim MC, Chang YJ, Won YJ, et al. Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1208320
BibTeX
@article{Lee2023,
author = {Lee, Eun-Gyeong and Lim, Jiwon and Ha, Hyeong In and Lim, Myong Cheol and Chang, Yoon Jung and Won, Young-Joo and Jung, So-Youn},
title = {Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1208320}
}
EUVIMED